These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 24391099

  • 1. Placental transfer of Fc-containing biopharmaceuticals across species, an industry survey analysis.
    Bowman CJ, Breslin WJ, Connor AV, Martin PL, Moffat GJ, Sivaraman L, Tornesi MB, Chivers S.
    Birth Defects Res B Dev Reprod Toxicol; 2013 Dec; 98(6):459-85. PubMed ID: 24391099
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Placental transfer of 125 iodinated humanized immunoglobulin G2Δa in the cynomolgus monkey.
    Catlin NR, Mitchell AZ, Potchoiba MJ, O'Hara DM, Wang M, Zhang M, Weinbauer GF, Bowman CJ.
    Birth Defects Res; 2020 Jan 01; 112(1):105-117. PubMed ID: 31746560
    [Abstract] [Full Text] [Related]

  • 4. An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies.
    Pentsuk N, van der Laan JW.
    Birth Defects Res B Dev Reprod Toxicol; 2009 Aug 01; 86(4):328-44. PubMed ID: 19626656
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Embryo/fetal toxicity assessment of lasofoxifene, a selective estrogen receptor modulator (SERM), in rats and rabbits.
    Ozolins TR, Gupta U.
    Birth Defects Res B Dev Reprod Toxicol; 2004 Jun 01; 71(3):161-70. PubMed ID: 15282737
    [Abstract] [Full Text] [Related]

  • 9. M281, an anti-FcRn antibody, inhibits IgG transfer in a human ex vivo placental perfusion model.
    Roy S, Nanovskaya T, Patrikeeva S, Cochran E, Parge V, Guess J, Schaeck J, Choudhury A, Ahmed M, Ling LE.
    Am J Obstet Gynecol; 2019 May 01; 220(5):498.e1-498.e9. PubMed ID: 30849355
    [Abstract] [Full Text] [Related]

  • 10. Investigation of maternal and fetal exposure to an IgG2 monoclonal antibody following biweekly intravaginal administration to cynomolgus monkeys throughout pregnancy.
    Moffat GJ, Davies R, Kwon G, Retter MW, Chellman GJ, Kanapuram S, Moore M, Loomis M, Wang W, Pyrah IT.
    Reprod Toxicol; 2014 Sep 01; 48():132-7. PubMed ID: 24859271
    [Abstract] [Full Text] [Related]

  • 11. Embryo-fetal distribution of a biopharmaceutical IgG2 during rat organogenesis.
    Bowman CJ, King LE, Stedman DB.
    Reprod Toxicol; 2012 Aug 01; 34(1):66-72. PubMed ID: 22543284
    [Abstract] [Full Text] [Related]

  • 12. Placental transfer of (125)Iodinated humanized immunoglobulin G2Δa in the Sprague Dawley rat.
    Coder PS, Thomas JA, Stedman DB, Bowman CJ.
    Reprod Toxicol; 2013 Jul 01; 38():37-46. PubMed ID: 23462583
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Embryo-fetal developmental toxicity of figitumumab, an anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody, in cynomolgus monkeys.
    Bowman CJ, Chmielewski G, Oneda S, Finco D, Boucher MA, Todd M.
    Birth Defects Res B Dev Reprod Toxicol; 2010 Aug 01; 89(4):326-38. PubMed ID: 20540090
    [Abstract] [Full Text] [Related]

  • 15. PDGFRα monoclonal antibody: Assessment of embryo-fetal toxicity and time-dependent placental transfer of a murine surrogate antibody of olaratumab in mice.
    Luffer-Atlas D, Reddy VR, Hilbish KG, Grace CE, Breslin WJ.
    Birth Defects Res; 2018 Nov 01; 110(18):1358-1371. PubMed ID: 30367709
    [Abstract] [Full Text] [Related]

  • 16. An Enhanced Pre- and Postnatal Development Study in Cynomolgus Monkeys with Tabalumab: A Human IgG4 Monoclonal Antibody.
    Breslin WJ, Hilbish KG, Martin JA, Halstead CA, Newcomb DL, Chellman GJ.
    Birth Defects Res B Dev Reprod Toxicol; 2015 Jun 01; 104(3):100-16. PubMed ID: 26195230
    [Abstract] [Full Text] [Related]

  • 17. Assessment of placental transfer and the effect on embryo-fetal development of a humanized monoclonal antibody targeting lymphotoxin-alpha in non-human primates.
    Wang H, Schuetz C, Arima A, Chihaya Y, Weinbauer GF, Habermann G, Xiao J, Woods C, Grogan J, Gelzleichter T, Cain G.
    Reprod Toxicol; 2016 Aug 01; 63():82-95. PubMed ID: 27211603
    [Abstract] [Full Text] [Related]

  • 18. Developmental immunotoxicology assessment of rituximab in cynomolgus monkeys.
    Vaidyanathan A, McKeever K, Anand B, Eppler S, Weinbauer GF, Beyer JC.
    Toxicol Sci; 2011 Jan 01; 119(1):116-25. PubMed ID: 20937725
    [Abstract] [Full Text] [Related]

  • 19. Maternal toxicokinetics, metabolism, and embryo exposure following a teratogenic dosing regimen with 13-cis-retinoic acid (isotretinoin) in the cynomolgus monkey.
    Hummler H, Hendrickx AG, Nau H.
    Teratology; 1994 Sep 01; 50(3):184-93. PubMed ID: 7871482
    [Abstract] [Full Text] [Related]

  • 20. Different embryo-fetal toxicity effects for three VLA-4 antagonists.
    Crofts F, Pino M, DeLise B, Guittin P, Barbellion S, Brunel P, Potdevin S, Bergmann B, Hofmann T, Lerman S, Clark RL.
    Birth Defects Res B Dev Reprod Toxicol; 2004 Apr 01; 71(2):55-68. PubMed ID: 15098199
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.